Pharma Orgs Lay Out Vaccine Access Plan Without IP Waiver
Organizations representing the branded-pharmaceutical industry have published their plan to expand vaccine production and distribution in a way that would not involve waiving intellectual property rights....To view the full article, register now.
Already a subscriber? Click here to view full article